Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Abstract 2230: Entinostat potentiates chemotherapeutic efficacy in small cell lung cancer cells

Anna Schwendenwein, Kristiina Boettiger, Ildiko Kovacs, Nandor Barany, Christian Lang, Zsolt Megyesfalvi, Michael Grusch, Walter Berger, Christian Kowol, Melinda Rezeli, Konrad Hoetzenecker, Balazs Döme, Karin Schelch

Cancer Res (2023) 83 (7_Supplement): 2230.

https://doi.org/10.1158/1538-7445.AM2023-2230

Published: 04 April 2023

View article titled, Abstract 2230: Entinostat potentiates chemotherapeutic efficacy in small cell lung cancer cells

Journal Articles

Abstract 1883: Treatment with histone deacetylase (HDAC) and BRAF inhibitors upregulates the expression of the plasma membrane Ca2+ pump, PMCA4b and alters intracellular Ca2+ handling in BRAF mutant melanoma cells

Luca Hegedus, Tamas Garay, Eszter Molnar, Karolina Varga, Rita Padanyi, Katalin Paszty, Balazs Hegedus, Mathias Wolf, Michael Grusch, Eniko Kallay, Agnes Enyedi

Cancer Res (2016) 76 (14_Supplement): 1883.

https://doi.org/10.1158/1538-7445.AM2016-1883

Published: 15 July 2016

View article titled, Abstract 1883: Treatment with histone deacetylase (HDAC) and BRAF inhibitors upregulates the expression of the plasma membrane Ca2+ pump, PMCA4b and alters intracellular Ca2+ handling in BRAF mutant melanoma cells

Journal Articles

Abstract 1671: Fibroblast growth factor receptor 3 enhances progression of hepatocellular carcinoma

Jakob Paur, Lisa Nika, Christiane Maier, Julia Kostka, Petra Heffeter, Sonja Kappel, Daniela Kandioler, Klaus Holzmann, Brigitte Marian, Walter Berger, Michael Grusch, Bettina Grasl-Kraupp

Cancer Res (2015) 75 (15_Supplement): 1671.

https://doi.org/10.1158/1538-7445.AM2015-1671

Published: 01 August 2015

View article titled, Abstract 1671: Fibroblast growth factor receptor 3 enhances progression of hepatocellular carcinoma

Journal Articles

Differential Effects of Polymorphic Alleles of FGF Receptor 4 on Colon Cancer Growth and Metastasis

Christine Heinzle, Andrea Gsur, Monika Hunjadi, Zeynep Erdem, Christine Gauglhofer, Stefan Stättner, Josef Karner, Martin Klimpfinger, Friedrich Wrba, Andrea Reti, Balazs Hegedus, Andreas Baierl, Bettina Grasl-Kraupp, Klaus Holzmann, Michael Grusch, Walter Berger, Brigitte Marian

Cancer Res (2012) 72 (22): 5767–5777.

https://doi.org/10.1158/0008-5472.CAN-11-3654

Published: 14 November 2012

View article titled, Differential Effects of Polymorphic Alleles of <em>FGF Receptor 4</em> on Colon Cancer Growth and Metastasis

Includes: Supplementary data

Journal Articles

Abstract 1203: Targeting FGFR4 in colorectal cancer cells

Christine Heinzle, Zeynep Erdem, Gudrun Sonvilla, Stefan Stättner, Josef Karner, Martin Klimpfinger, Bettina Grasl-Kraupp, Klaus Holzmann, Michael Grusch, Walter Berger, Brigitte Marian

Cancer Res (2012) 72 (8_Supplement): 1203.

https://doi.org/10.1158/1538-7445.AM2012-1203

Published: 15 April 2012

View article titled, Abstract 1203: Targeting FGFR4 in colorectal cancer cells

Journal Articles

Abstract 1067: Targeting the fibroblast growth factor receptor axis in malignant pleural mesothelioma

Mir Alireza Hoda, Karin Schelch, Christine Pirker, Bahil Ghanim, Thomas Klikovits, Viktoria Laszlo, Ulrike Setinek, Martin Filipits, Balazs Dome, Balazs Hegedues, Brigitte Marian, Bettina Grasl-Kraupp, Walter Klepetko, Walter Berger, Michael Grusch

Cancer Res (2012) 72 (8_Supplement): 1067.

https://doi.org/10.1158/1538-7445.AM2012-1067

Published: 15 April 2012

View article titled, Abstract 1067: Targeting the fibroblast growth factor receptor axis in malignant pleural mesothelioma

Journal Articles

Abstract 1229: Fibroblast growth factor signaling in ovarian cancer

Manuel Brantner, Renate Wagner, Michael Grusch, Walter Berger, Klaus Holzmann, Brigitte Marian, Thomas W. Grunt

Cancer Res (2012) 72 (8_Supplement): 1229.

https://doi.org/10.1158/1538-7445.AM2012-1229

Published: 15 April 2012

View article titled, Abstract 1229: Fibroblast growth factor signaling in ovarian cancer

Journal Articles

Abstract 5142: Detection of genomic changes in glioblastoma stem cell subpopulations by array comparative genomic hybridisation

Daniela Loetsch, Christine Pirker, Sabine Spiegl-Kreinecker, Michael Grusch, Johannes Fischer, Michael Micksche, Walter Berger

Cancer Res (2010) 70 (8_Supplement): 5142.

https://doi.org/10.1158/1538-7445.AM10-5142

Published: 15 April 2010

View article titled, Abstract 5142: Detection of genomic changes in glioblastoma stem cell subpopulations by array comparative genomic hybridisation

Journal Articles

Abstract #4419: HER receptors and fatty acid synthase in ovarian cancer: Molecular rationales for co-targeting approaches

Thomas Grunt, Renate Wagner, Michael Grusch, Walter Berger, Christian Singer, Brigitte Marian, Christoph Zielinski, Ruth Lupu

Cancer Res (2009) 69 (9_Supplement): 4419.

Published: 01 May 2009

View article titled, Abstract #4419: HER receptors and fatty acid synthase in ovarian cancer: Molecular rationales for co-targeting approaches

Journal Articles

Abstract #4286: Expression of activins and follistatins in glioblastoma

Michael Grusch, Andreas Lackner, Sabine Spiegl-Kreinecker, Daniela Lötsch, Christine Pirker, Barbara Peter-Vörösmarty, Thomas Metzner, Deniz Öztürk, Michael Micksche, Walter Berger

Cancer Res (2009) 69 (9_Supplement): 4286.

Published: 01 May 2009

View article titled, Abstract #4286: Expression of activins and follistatins in glioblastoma

Journal Articles

Abstract #2830: FGF5/FGFR1-mediated signals as therapeutic targets in human glioblastoma multiforme

Walter Berger, Sigrid Allerstorfer, Hendrik Fischer, Sabine Spiegl-Kreinecker, Christine Marosi, Johanna Buchroithner, Johannes Fischer, Josef Picher, Klaus Holzmann, Bettina Grasl-Kraupp, Brigitte Marian, Michael Micksche, Michael Grusch

Cancer Res (2009) 69 (9_Supplement): 2830.

Published: 01 May 2009

View article titled, Abstract #2830: FGF5/FGFR1-mediated signals as therapeutic targets in human glioblastoma multiforme

Journal Articles

Abstract #2776: Resistance against the irreversible dual EGFR/HER2 inhibitor pelitinib (EKB-569) correlates with hyperactive HER3/PI3K/AKT signaling

Waheed Shabbir, Caroline Brünner-Kubath, Michael Grusch, Walter Berger, Brigitte Marian, Christian Singer, Renate Wagner, Christoph Zielinski, Thomas Grunt

Cancer Res (2009) 69 (9_Supplement): 2776.

Published: 01 May 2009

View article titled, Abstract #2776: Resistance against the irreversible dual EGFR/HER2 inhibitor pelitinib (EKB-569) correlates with hyperactive HER3/PI3K/AKT signaling

Journal Articles

NORE1B Is a Putative Tumor Suppressor in Hepatocarcinogenesis and May Act via RASSF1A

Doris Macheiner, Christine Gauglhofer, Chantal Rodgarkia-Dara, Michael Grusch, Andreas Brachner, Christoph Bichler, Daniela Kandioler, Hedwig Sutterlüty, Wolfgang Mikulits, Rolf Schulte-Hermann, Bettina Grasl-Kraupp

Cancer Res (2009) 69 (1): 235–242.

https://doi.org/10.1158/0008-5472.CAN-08-2144

Published: 31 December 2008

View article titled, NORE1B Is a Putative Tumor Suppressor in Hepatocarcinogenesis and May Act via RASSF1A

Journal Articles

Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer cell growth and migration

Gudrun Sonvilla, Sigrid Allerstorfer, Stefan Stattner, Josef Karner, Martin Klimpfinger, Hendrik Fischer, Christine Gaugelhofer, Bettina Grasl-Kraupp, Michael Grusch, Klaus Holzmann, Walter Berger, Friedrich Wrba, Brigitte Marian

Cancer Res (2008) 68 (9_Supplement): 135.

Published: 01 May 2008

View article titled, Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer cell growth and migration

Journal Articles

Synergistic activity of combined FGFR and EGFR inhibition in non-small cell lung cancer

Fischer Hendrik, Ninon Taylor, Sigrid Allerstorfer, Michael Grusch, Gudrun Sonvilla, Klaus Holzmann, Ulrike Setinek, Leonilla Elbling, Heidelinde Cantonati, Bettina Grasl-Kraupp, Christine Gauglhofer, Brigitte Marian, Michael Micksche, Walter Berger

Cancer Res (2008) 68 (9_Supplement): 141.

Published: 01 May 2008

View article titled, Synergistic activity of combined FGFR and EGFR inhibition in non-small cell lung cancer

Journal Articles

Biochemical effects of Piceatannol in human HL-60 promyelocytic leukemia cells - synergism with Ara-C

Philipp Saiko, Monika Fritzer-Szekeres, Ivo Savinc, Zsuzsanna Horvath, Astrid Bernhaus, Maria Ozsvar-Kozma, Michael Grusch, Walter Jaeger, Thomas Szekeres

Cancer Res (2006) 66 (8_Supplement): 1113.

Published: 15 April 2006

View article titled, Biochemical effects of Piceatannol in human HL-60 promyelocytic leukemia cells - synergism with Ara-C

Journal Articles

Overexpression of follistatin and follistatin-like 3 may be involved in hepatocarcinogenesis

Michael Grusch, Claudia Drucker, Barbara Peter-Vörösmarty, Natascha Erlach, Annemarie Loser, Wolfram Parzefall, Walter Berger, Bettina Grasl-Kraupp, Rolf Schulte-Hermann

Cancer Res (2006) 66 (8_Supplement): 718–719.

Published: 15 April 2006

View article titled, Overexpression of follistatin and follistatin-like 3 may be involved in hepatocarcinogenesis

Journal Articles

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) stimulates growth of liver tumor-prestages and may act in inflammation-driven hepatocarcinogenesis

Bettina Grasl-Kraupp, Claudia Drucker, Annemarie Losert, Michael Grusch, Doris Macheiner, Wolfram Parzefall, Rolf Schulte-Hermann

Cancer Res (2006) 66 (8_Supplement): 19.

Published: 15 April 2006

View article titled, Heparin-binding epidermal growth factor-like growth factor (HB-EGF) stimulates growth of liver tumor-prestages and may act in inflammation-driven hepatocarcinogenesis

Journal Articles

Inhibition of her1 and her2 in hepatoma cells

Michael Grusch, Annemarie Losert, Natascha Erlach, Barbara Peter-Vörösmarty, Rolf Schulte-Hermann

Cancer Res (2005) 65 (9_Supplement): 1195.

Published: 01 May 2005

View article titled, Inhibition of her1 and her2 in hepatoma cells

Journal Articles

Differential antineoplastic and biochemical effects of resveratrol and 3,3’,4,4’,5,5’-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells

Monika Fritzer-Szekeres, Zsuzsanna Horvath, Philipp Saiko, Christoph Illmer, Sibylle Madlener, Michael Grusch, Marek Murias, Walter Jaeger, Norbert Handler, Thomas Erker, Maria Ozsvar-Kozma, Thomas Szekeres

Cancer Res (2005) 65 (9_Supplement): 152.

Published: 01 May 2005

View article titled, Differential antineoplastic and biochemical effects of resveratrol and 3,3’,4,4’,5,5’-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells

NARROW

Abstract 2230: Entinostat potentiates chemotherapeutic efficacy in small cell lung cancer cells

Abstract 1883: Treatment with histone deacetylase (HDAC) and BRAF inhibitors upregulates the expression of the plasma membrane Ca2+ pump, PMCA4b and alters intracellular Ca2+ handling in BRAF mutant melanoma cells

Abstract 1671: Fibroblast growth factor receptor 3 enhances progression of hepatocellular carcinoma

Differential Effects of Polymorphic Alleles of FGF Receptor 4 on Colon Cancer Growth and Metastasis

Abstract 1203: Targeting FGFR4 in colorectal cancer cells

Abstract 1067: Targeting the fibroblast growth factor receptor axis in malignant pleural mesothelioma

Abstract 1229: Fibroblast growth factor signaling in ovarian cancer

Abstract 5142: Detection of genomic changes in glioblastoma stem cell subpopulations by array comparative genomic hybridisation

Abstract #4419: HER receptors and fatty acid synthase in ovarian cancer: Molecular rationales for co-targeting approaches

Abstract #4286: Expression of activins and follistatins in glioblastoma

Abstract #2830: FGF5/FGFR1-mediated signals as therapeutic targets in human glioblastoma multiforme

Abstract #2776: Resistance against the irreversible dual EGFR/HER2 inhibitor pelitinib (EKB-569) correlates with hyperactive HER3/PI3K/AKT signaling

NORE1B Is a Putative Tumor Suppressor in Hepatocarcinogenesis and May Act via RASSF1A

Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer cell growth and migration

Synergistic activity of combined FGFR and EGFR inhibition in non-small cell lung cancer

Biochemical effects of Piceatannol in human HL-60 promyelocytic leukemia cells - synergism with Ara-C

Overexpression of follistatin and follistatin-like 3 may be involved in hepatocarcinogenesis

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) stimulates growth of liver tumor-prestages and may act in inflammation-driven hepatocarcinogenesis

Inhibition of her1 and her2 in hepatoma cells

Differential antineoplastic and biochemical effects of resveratrol and 3,3’,4,4’,5,5’-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only